Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study

Agnelli G (1997) Venous thromboembolism and cancer: a two-way clinical association. Thromb Haemost 78(1):117–120 PMID: 9198139

Article  CAS  PubMed  Google Scholar 

Noble S, Pasi J (2010) Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 102(Suppl 1):S2–9

Article  PubMed  PubMed Central  Google Scholar 

Mahé I, Sterpu R, Bertoletti L, López-Jiménez L, Mellado Joan M, Trujillo-Santos J, Ballaz A, Hernández Blasco LM, Marchena PJ, Monreal M (2015) RIETE investigators. Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? PLoS ONE 10(6):e0128741

Article  PubMed  PubMed Central  Google Scholar 

Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35(3):664–670

Article  PubMed  Google Scholar 

Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119(1):1–16

Article  CAS  PubMed  Google Scholar 

Martinelli I, De Stefano V (2010) Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review. Thromb Haemost 103(6):1136–1144

Article  CAS  PubMed  Google Scholar 

Ferro JM, Canhão P, Aguiar de Sousa D (2016) Cerebral venous thrombosis. Presse Med 45(12 Pt 2):e429–e450

Article  PubMed  Google Scholar 

Dentali F, Gianni M, Crowther MA, Ageno W (2006) Natural history of cerebral vein thrombosis: a systematic review. Blood 108(4):1129–1134

Article  CAS  PubMed  Google Scholar 

Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY, American Heart Association Stroke Council and the Council on Epidemiology and Prevention (2011) Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(4):1158–1192

Article  PubMed  Google Scholar 

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, Thurston C, Vedantham S, Verhamme P, Witt DM, Florez D, Izcovich I, Nieuwlaat A, Ross R, Schünemann SJ, Wiercioch H, Zhang W, Zhang Y (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693–4738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484–3488

Article  CAS  PubMed  Google Scholar 

Chee CE, Ashrani AA, Marks RS, Petterson TM, Bailey KR, Melton LJ 3rd, Heit JA (2014) Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood 123(25):3972–3978

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yaghi S, Shu L, Bakradze E, Salehi Omran S, Giles JA, Amar JY, Henninger N, Elnazeir M, Liberman AL, Moncrieffe K, Lu J, Sharma R, Cheng Y, Zubair AS, Simpkins AN, Li GT, Kung JC, Perez D, Heldner M, Scutelnic A, Seiffge D, Siepen B, Rothstein A, Khazaal O, Do D, Kasab SA, Rahman LA, Mistry EA, Kerrigan D, Lafever H, Nguyen TN, Klein P, Aparicio H, Frontera J, Kuohn L, Agarwal S, Stretz C, Kala N, El Jamal S, Chang A, Cutting S, Xiao H, de Havenon A, Muddasani V, Wu T, Wilson D, Nouh A, Asad SD, Qureshi A, Moore J, Khatri P, Aziz Y, Casteigne B, Khan M, Cheng Y, Mac Grory B, Weiss M, Ryan D, Vedovati MC, Paciaroni M, Siegler JE, Kamen S, Yu S, Leon Guerrero CR, Atallah E, De Marchis GM, Brehm A, Dittrich T, Psychogios M, Alvarado-Dyer R, Kass-Hout T, Prabhakaran S, Honda T, Liebeskind DS, Furie K (2022) Direct oral anticoagulants versus Warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke 53(3):728–738

Article  CAS  PubMed  Google Scholar 

Liberman AL, Kamel H, Mullen MT, Messé SR (2016) International classification of diseases, Ninth Revision (ICD-9) diagnosis codes can identify cerebral venous thrombosis in hospitalized adults. Neurohospitalist 6(4):147–150

Article  PubMed  PubMed Central  Google Scholar 

Handley JD, Emsley HC (2020) Validation of ICD-10 codes shows intracranial venous thrombosis incidence to be higher than previously reported. Health Inf Manag 49(1):58–61

PubMed  Google Scholar 

Salehi Omran S, Shu L, Chang A, Parikh NS, Zubair AS, Simpkins AN, Heldner MR, Hakim A, Kasab SA, Nguyen T, Klein P, Goldstein ED, Vedovati MC, Paciaroni M, Liebeskind DS, Yaghi S, Cutting S (2023) Timing and predictors of recanalization after anticoagulation in cerebral venous thrombosis. J Stroke 25(2):291–298

Article  PubMed  PubMed Central  Google Scholar 

Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, Noble S, Sexton EA, Stenehjem D, Wiercioch W, Kahale LA, Alonso-Coello P (2021) American society of hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5(4):927–974

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bates SM, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. ;126(3 Suppl):627S-644S

Miranda B, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, Scoditti U (2010) ISCVT investigators. Venous thromboembolic events after cerebral vein thrombosis. Stroke 41(9):1901–1906

Article  PubMed  Google Scholar 

Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, Siragusa S, Kostal M, Palareti G, Sartori MT, Grandone E, Vedovati MC, Ageno W; CErebral VEin Thrombosis International Study Investigators, Falanga A, Lerede T, Bianchi M, Testa S, Witt D, McCool K, Bucherini E, Grifoni E, Coalizzo D, Benedetti R, Marietta M, Sessa M, Guaschino C, di Minno G, Tufano A, Barbar S, Malato A, Pini M, Castellini P, Barco S, Barone M, Paciaroni M, Alberti A, Agnelli G, Giorgi Pierfranceschi M, Dulicek P, Silingardi M, Federica L, Ghirarduzzi A, Tiraferri E, di Lazzaro V, Rossi E, Ciminello A, Pasca S, Barillari G, Rezoagli E, Galli M, Squizzato A, Tosetto A (2012) Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost. ;10(7):1297 – 302

Abelhad NI, Qiao W, Garg N, Rojas-Hernandez CM (2021) Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer. Thromb J 19(1):37

Article  PubMed  PubMed Central  Google Scholar 

Coutinho JM, Stam J, Canhão P, Barinagarrementeria F, Bousser MG, Ferro JM (2015) ISCVT investigators. Cerebral venous thrombosis in the absence of headache. Stroke 46(1):245–247

Article  PubMed  Google Scholar 

Coutinho JM, Gerritsma JJ, Zuurbier SM, Stam J (2014) Isolated cortical vein thrombosis. Syst Rev case Rep case Ser Stroke 45:1836–1838

Google Scholar 

Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F (2005) ISCVT investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 36:1927–1932

Ferro JM, Melo TP, Oliveira V, Salgado AV, Crespo M, Canhão P et al (1995) A multivariate study of headache associated with ischemic stroke. Headache. 35:315–319

Melo TP, Pinto AN, Ferro JM (1996) Headache intracerebral. Hematomas Neurol 47:494–500

CAS  Google Scholar 

Duman T, Uluduz D, Midi I, Bektas H, Kablan Y, Goksel BK, Milanlioglu A, Necioglu Orken D, Aluclu U, VENOST Study Group (2017) A Multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis 26(8):1848–1857

Article  PubMed  Google Scholar 

Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M (2020) Caravaggio Investigators. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med 382(17):1599–1607

Article  CAS  PubMed  Google Scholar 

Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Frässdorf M, Huisman H, Reilly P, Diener HC, RE-SPECT CVT Study Group (2019) Safety and Efficacy of Dabigatran Etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurol 76(12):1457–1465

Article  PubMed  PubMed Central  Google Scholar 

Rothrock JF, Diener HC (2021) Headache secondary to cerebrovascular disease. Cephalalgia 41(4):479–492

Article  PubMed  Google Scholar 

Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, Fox AA, Gencer K, Halperin B, Hijazi JL, Hohnloser Z, Hua SH, Hylek K, Toda Kato E, Kuder E, Lopes J, Mahaffey RD, Oldgren KW, Piccini J, Ruff JP, Steffel CT, Wojdyla J, Granger D (2022) COMBINE AF (a collaboration between multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) investigators. Direct oral anticoagulants Versus Warfarin in patients with Atrial Fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation 145(4):242–255

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968–1975

Article  PubMed  Google Scholar 

Cheung YW, Middeldorp S, Prins MH, Pap AF, Lensing AW, Ten Cate-Hoek AJ, Villalta S, Milan M, Beyer-Westendorf J, Verhamme P, Bauersachs RM, Prandoni P, Einstein PTS, Investigators Group (2016) Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis. Thromb Haemost 116(4):733–738

PubMed  Google Scholar 

留言 (0)

沒有登入
gif